NASDAQ · Biotechnology

DRUG (DRUG) Stock

$72.11 +0.28% NASDAQ: DRUG Healthcare

Valuation

MetricValue
Price$72.11
Market Cap$705.75M
P/E Ratio-4.91
P/B Ratio2.64
P/S Ratio0.00
EPS (TTM)$-10.64
52-Week High$123.75
52-Week Low$23.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-15.02%
ROA-10.44%
ROCE-17.07%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio42.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-9.0M$-15.0M$-7.0M$-3.0M$-14.0M
Net Profit$-9.0M$-15.0M$-7.0M$-3.0M$-12.0M
EPS$-4.74$-6.15$-1.98$-0.65$-1.78
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$12.0M$7.0M$6.0M$84.0M
Total Liabilities$1.0M$2.0M$0$1.0M$2.0M
Cash$20.0M$12.0M$7.0M$6.0M$83.0M
Borrowings$0$0$0$0$0

Latest News

All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy Zacks · Jul 22, 2026 Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline Motley Fool · May 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-14.0M$-7.0M$-2.0M$-9.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$-2.0M$1.0M$1.0M$0$0
Net Cash Flow$19.0M$-8.0M$-5.0M$-1.0M$77.0M
Free Cash Flow$-7.0M$-14.0M$-7.0M$-2.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-3.10%
Quick Ratio81.48
Interest Coverage—
Return 1Y138.59%
Return 3Y1816.40%
Return 5Y229.02%

Ownership

Insiders Held12.00%
Institutions Held93.00%
Institutions Float Held105.69%
Institutional HolderSharesReport Date
Janus Henderson Group PLC1,284,3242026-03-31
Cormorant Asset Management, LP1,059,3312026-03-31
Blackrock Inc.621,9332026-03-31
Vivo Capital, LLC557,1722026-03-31
Braidwell LP 539,7082026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About DRUG

DRUG is led by CEO Ian McDonald, employs 26 people, headquartered in CA, publicly traded since 2021.

DRUG stock trades at $72.11 with a market capitalization of $705.75M. The stock is valued at a price-to-earnings (P/E) ratio of -4.91, price-to-book of 2.64, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $23.18 and $123.75, and currently trades 41.7% below its 52-week high.

On profitability, DRUG generates a return on equity (ROE) of -15.02%, return on capital employed of -17.07%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides